AB Volvo (publ) (VLVLY)

CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	61,868	49,415	53,150	37,178	47,293	48,072
Market Cap Growth	8.69%	-7.03%	42.96%	-21.39%	-1.62%	40.53%
Enterprise Value	83,576	66,094	70,723	50,910	59,282	58,847
Last Close Price	30.42	22.86	23.40	15.42	18.53	17.09
PE Ratio	15.46	10.85	10.73	11.84	13.04	20.44
PS Ratio	1.18	1.04	0.97	0.82	1.15	1.17
PB Ratio	3.52	2.77	2.96	2.33	2.97	2.67
P/TBV Ratio	4.89	3.65	3.95	3.20	4.11	3.57
P/FCF Ratio	23.14	16.80	64.59	30.31	27.54	24.20
P/OCF Ratio	13.77	11.78	24.98	11.66	12.71	12.90
EV/Sales Ratio	1.59	1.39	1.29	1.12	1.44	1.43
EV/EBITDA Ratio	13.13	9.77	8.18	10.04	11.45	14.80
EV/EBIT Ratio	15.78	10.77	8.82	11.31	12.97	17.01
EV/FCF Ratio	31.26	22.47	85.94	41.50	34.52	29.63
Debt / Equity Ratio	1.59	1.34	1.32	1.29	1.07	1.04
Debt / EBITDA Ratio	4.23	3.43	2.68	3.89	3.16	4.44
Debt / FCF Ratio	10.45	8.13	28.91	16.74	9.90	9.45
Asset Turnover	0.73	0.76	0.85	0.83	0.73	0.65
Inventory Turnover	4.47	4.76	5.10	5.05	4.95	4.86
Quick Ratio	0.76	0.96	0.90	0.95	0.92	0.96
Current Ratio	1.11	1.27	1.24	1.29	1.26	1.38
Return on Equity (ROE)	22.41%	26.75%	28.78%	21.25%	22.75%	13.85%
Return on Assets (ROA)	4.77%	6.12%	7.74%	5.12%	5.03%	3.43%
Return on Capital (ROIC)	7.56%	9.63%	12.60%	8.65%	8.61%	5.90%
Return on Capital Employed (ROCE)	13.80%	15.70%	20.70%	12.40%	13.20%	9.20%
Earnings Yield	6.47%	9.21%	9.32%	8.44%	7.67%	4.89%
FCF Yield	4.32%	5.95%	1.55%	3.30%	3.63%	4.13%
Dividend Yield	5.02%	3.16%	3.19%	4.35%	3.88%	4.28%
Payout Ratio	42.74%	30.27%	28.57%	40.39%	37.21%	-
Total Shareholder Return	5.02%	3.16%	3.19%	4.35%	3.88%	4.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.